ACKR2 and COVID-19: Furthermore, recovery from severe SARS-CoV-2 infection involves an expansion of ACKR2-expressing ILC2 cells, underscoring the importance of targeting this subset to promote lung recovery in COVID-19 and other related diseases [26].